| OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus’ phenotypes P Amati-Bonneau, ML Valentino, P Reynier, ME Gallardo, B Bornstein, ... Brain 131 (2), 338-351, 2008 | 566 | 2008 |
| Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection A Méndez-Guerrero, MI Laespada-García, A Gómez-Grande, M Ruiz-Ortiz, ... Neurology 95 (15), e2109-e2118, 2020 | 166 | 2020 |
| Generalized myoclonus in COVID-19 P Rábano-Suárez, L Bermejo-Guerrero, A Méndez-Guerrero, ... Neurology 95 (6), e767-e772, 2020 | 152 | 2020 |
| Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: the FYDATA study V Villanueva, M Garcés, FJ López-González, X Rodriguez-Osorio, ... Epilepsy research 126, 201-210, 2016 | 123 | 2016 |
| BRIVA‐LIFE–A multicenter retrospective study of the long‐term use of brivaracetam in clinical practice V Villanueva, FJ López‐González, JA Mauri, J Rodriguez‐Uranga, ... Acta neurologica Scandinavica 139 (4), 360-368, 2019 | 71 | 2019 |
| Higher glutamate to glutamine ratios in occipital regions in women with migraine during the interictal state J Gonzalez de la Aleja, A Ramos, V Mato‐Abad, A Martínez‐Salio, ... Headache: The Journal of Head and Face Pain 53 (2), 365-375, 2013 | 60 | 2013 |
| Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide V Villanueva, FJ López, JM Serratosa, B González-Giraldez, D Campos, ... Epilepsy & Behavior 29 (2), 349-356, 2013 | 52 | 2013 |
| NEOPLASM study: real-life use of lacosamide in patients with brain tumor-related epilepsy V Villanueva, R Saiz-Diaz, M Toledo, A Piera, JA Mauri, ... Epilepsy & Behavior 65, 25-32, 2016 | 37 | 2016 |
| Gabapentin for painful legs and moving toes syndrome. A Villarejo, J Porta-Etessam, A Camacho, JG de Ia Aleja, A Martínez-Salio, ... European neurology 51 (3), 2004 | 23 | 2004 |
| Effects of alprazolam on cortical activity and tremors in patients with essential tremor J Ibáñez, J González de la Aleja, JA Gallego, JP Romero, RA Saíz-Díaz, ... PLoS One 9 (3), e93159, 2014 | 20 | 2014 |
| Mechanical vibration does not systematically reduce the tremor in essential tremor patients JS Lora-Millán, R López-Blanco, JÁ Gallego, A Méndez-Guerrero, ... Scientific Reports 9 (1), 16476, 2019 | 19 | 2019 |
| Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms VA Blanco-Palmero, FJ Azcárate-Díaz, M Ruiz-Ortiz, MI Laespada-García, ... Journal of Neurology 268, 3116-3124, 2021 | 16 | 2021 |
| Brain Magnetic Resonance Spectroscopy Findings in the Stroke‐like Migraine Attacks after Radiation Therapy (SMART) Syndrome E Gómez‐Cibeira, P Calleja‐Castaño, J Gonzalez de la Aleja, ... Journal of Neuroimaging 25 (6), 1056-1058, 2015 | 16 | 2015 |
| A new MR radiological sign in HaNDL syndrome. A case report C Rodríguez-López, NG Caldas, DUP de Urabayen, MS Tornero, ... Journal of Clinical Neuroscience 61, 274-276, 2019 | 13 | 2019 |
| Symptomatic atherosclerotic disease and decreased risk of cancer-specific mortality: a prospective, population-based study (NEDICES) J Benito-Leon, JG De La Aleja, A Martínez-Salio, ED Louis, JH Lichtman, ... Medicine 94 (32), e1287, 2015 | 12 | 2015 |
| High‐dose oral glutamine supplementation reduces elevated glutamate levels in cerebrospinal fluid in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke … MP Guerrero‐Molina, M Morales‐Conejo, A Delmiro, M Morán, ... European Journal of Neurology 30 (2), 538-547, 2023 | 11 | 2023 |
| Elevated glutamate and decreased glutamine levels in the cerebrospinal fluid of patients with MELAS syndrome MP Guerrero-Molina, M Morales-Conejo, A Delmiro, M Morán, ... Journal of Neurology 269 (6), 3238-3248, 2022 | 10 | 2022 |
| Clinical, genetic and quality-of-life study of a cohort of adult patients with tuberous sclerosis EC De Sautu De Borbón, JM Guerra Vales, C Lumbreras Bermejo, ... Orphanet Journal of Rare Diseases 16, 1-10, 2021 | 7 | 2021 |
| Relief of intractable posthypoxic myoclonus after administration of agomelatine JG de la Aleja, RA Saiz-Díaz, P De la Peña Clinical Neuropharmacology 35 (5), 258-259, 2012 | 7 | 2012 |
| Fisiopatología de la migraña. Reflexiones sobre la hipótesis glutamatérgica JG de la Alejaa, J Porta-Etessamb, JM Sepúlveda-Sáncheza, ... Rev Neurol 43 (8), 481-488, 2006 | 6 | 2006 |
